Brainsway Ltd (BWAY)vsGE HealthCare Technologies Inc. (GEHC)
BWAY
Brainsway Ltd
$13.50
-1.53%
HEALTHCARE · Cap: $536.38M
GEHC
GE HealthCare Technologies Inc.
$72.20
+1.75%
HEALTHCARE · Cap: $32.38B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 39393% more annual revenue ($20.63B vs $52.23M). BWAY leads profitability with a 14.6% profit margin vs 10.1%. GEHC trades at a lower P/E of 15.6x. GEHC earns a higher WallStSmart Score of 60/100 (C+).
BWAY
Hold46
out of 100
Grade: D+
GEHC
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-178.3%
Fair Value
$8.42
Current Price
$13.50
$5.08 premium
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$72.20
$41.26 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 27.4% year-over-year
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Areas to Watch
3.9% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BWAY
The strongest argument for BWAY centers on Revenue Growth. Revenue growth of 27.4% demonstrates continued momentum.
Bull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bear Case : BWAY
The primary concerns for BWAY are EPS Growth, Market Cap, P/E Ratio. A P/E of 75.9x leaves little room for execution misses.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
BWAY profiles as a growth stock while GEHC is a value play — different risk/reward profiles.
GEHC carries more volatility with a beta of 1.18 — expect wider price swings.
BWAY is growing revenue faster at 27.4% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Bottom Line
GEHC scores higher overall (60/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Brainsway Ltd
HEALTHCARE · MEDICAL DEVICES · USA
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?